Trial Information
Generic NameMethylphenidate HClProduct NameCONCERTA®Therapeutic AreaBehaviors and Mental DisordersEnrollment1323% Female25.7%% White76.7%
Product ClassStimulants/ADHD/AnorexiantsSponsor Protocol NumberCR008329 (12-101)Data PartnerJohnson & JohnsonCondition StudiedAttention Deficit Hyperactivity DisorderMean/Median Age (Years)8.9
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2024-0860 : Predicting Methylphenidate Response in Adult-ADHD (A-ADHD) Using Machine Learning Approaches
- 2023-5195 : Predictive modeling of adverse events and symptoms patterns in large scale clinical trials
- 2019-3958 : Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.
- 2016-0994 : Applications of Item Response Theory to Clinical ADHD Research: Increased Precision of Treatment Effect Estimation
- 2015-0592 : Detection of uninformative clinics during the trial of a new drug using statistical and machine learning techniques
- 2015-0539 : Applications of Item Response Theory to Clinical ADHD Research: Analysis of the Psychometric Properties of the ADHDRS-IV